Clinical Trial Update: The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study assessing the effects of caffeine and chlorogenic acid supplementation on inflammatory, metabolic factors, hepatic steatosis and fibrosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Caffeine (caffeine)
• Chlorogenic acid (chlorogenic acid)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Type 2 Diabetes Nonalcoholic Fatty Liver | Phase 2, Phase 3 | Status: COMPLETED